Atlas Venture Life Science Advisors, LLC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.

Quarter-by-quarter ownership
Atlas Venture Life Science Advisors, LLC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$88,573,623
-20.4%
9,885,4490.0%13.72%
-0.9%
Q2 2023$111,211,301
-2.3%
9,885,4490.0%13.84%
-10.2%
Q1 2023$113,880,372
-0.4%
9,885,449
+0.2%
15.42%
+11.9%
Q4 2022$114,387,308
+0.8%
9,869,483
+10.5%
13.78%
+10.0%
Q3 2022$113,473,000
+84.9%
8,934,9020.0%12.52%
+22.0%
Q2 2022$61,383,000
-28.7%
8,934,9020.0%10.26%
-5.8%
Q1 2022$86,132,000
-18.9%
8,934,9020.0%10.89%
+11.6%
Q4 2021$106,236,0008,934,9029.76%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders